U.S. RESEARCH ROUNDUP-Abbvie, Eli Lilly, Vroom
18/11/2022 07:19
Nov 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Abbvie, Eli Lilly, and Vroom, on Friday.
HIGHLIGHTS
* Abbvie Inc ABBV.N : Credit Suisse initiates coverage with outperform rating
* Bristol-Myers Squibb Co BMY.N : Credit Suisse initiates coverage with neutral
rating
* Eli Lilly LLY.N : Credit Suisse initiates coverage with outperform rating
* Merck & Co Inc MRK.N : Credit Suisse initiates coverage with outperform rating
* Vroom Inc VRM.O : JP Morgan raises to neutral from underweight
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries
are in alphabetical order.
* Abbvie Inc ABBV.N : Credit Suisse initiates coverage with outperform rating
* Abbvie Inc ABBV.N : Credit Suisse initiates coverage with target price $170
* Alibaba Group BABA.N : JP Morgan raises target price to $140 from $135
* America'S Car-Mart Inc CRMT.O : Jefferies cuts target price to $66 from $68
* America'S Car-Mart Inc CRMT.O : Stephens cuts target price to $72 from $83
* Amgen Inc AMGN.O : Credit Suisse initiates coverage with underperform rating
* Amgen Inc AMGN.O : Credit Suisse initiates coverage with target price $240
* API Group Corp APG.N : RBC raises target price to $20 from $18
* Applied Materials Inc AMAT.O : Bernstein raises target price to $130 from $120
* Applied Materials Inc AMAT.O : D.A. Davidson raises target price to $125 from $105
* Applied Materials Inc AMAT.O : JP Morgan raises target price to $120 from $115
* Applied Materials Inc AMAT.O : Wells Fargo raises target price to $115 from $100
* Baker Hughes Co BKR.O : Jefferies raises target price to $36 from $35
* Bath & Body Works Inc BBWI.N : Barclays cuts target price to $39 from $42
* Bath & Body Works Inc BBWI.N : Jefferies raises target price to $45 from $43
* Biocardia Inc BCDA.O : Alliance Global Partners cuts target price to $6 from $11.5
* BJ's Wholesale Club Holdings Inc BJ.N : JP Morgan raises target price to $65 from $64
* Bristol-Myers Squibb Co BMY.N : Credit Suisse initiates coverage with neutral rating
* Bristol-Myers Squibb Co BMY.N : Credit Suisse initiates coverage with target price $78
* Cheniere Energy Inc LNG.A : JP Morgan raises target price to $222 from $218
* Destination Xl Group Inc DXLG.O : D.A. Davidson raises target price to $9
* Editas Medicine Inc EDIT.O : Baird cuts target price to $18 from $25
* Editas Medicine Inc EDIT.O : Chardan Capital Markets cuts target price to $35 from $43
* Editas Medicine Inc EDIT.O : Credit Suisse cuts to neutral from outperform
* Editas Medicine Inc EDIT.O : Credit Suisse cuts target price to $13 from $25
* Editas Medicine Inc EDIT.O : Oppenheimer cuts to perform from outperform
* Editas Medicine Inc EDIT.O : Oppenheimer cuts target price to $12 from $28
* Editas Medicine Inc EDIT.O : RBC cuts target price to $14 from $32
* Eli Lilly LLY.N : Credit Suisse initiates coverage with outperform rating
* Eli Lilly LLY.N : Credit Suisse initiates coverage with target price $395
* Enveric Biosciences Inc ENVB.O : Alliance Global Partners raises target to $7 from
$1.25
* Envista Holdings Corp NVST.N : Jefferies cuts target price to $44 from $50
* Equifax Inc EFX.N : JP Morgan raises target price to $219 from $196
* Evolent Health Inc EVH.N : Cowen and Company raises target price to $57 from $52
* Ezcorp Inc EZPW.O : Jefferies raises target price to $13 from $11
* Gap Inc GPS.N : Jefferies raises target price to $13 from $11
* Halliburton Co HAL.N : Jefferies raises target price to $44 from $40
* Helmerich and Payne Inc HP.N : Atb Capital Markets raises target price to $71 from $66
* Helmerich and Payne Inc HP.N : RBC raises target price to $68 from $63
* I3 Verticals Inc IIIV.O : D.A. Davidson raises target price to $36 from $34
* Ideaya Biosciences Inc IDYA.O : Baird raises target price to $24 from $18
* Inotiv Inc NOTV.O : Jefferies cuts target price to $10 from $27
* Isun Inc ISUN.O : Alliance Global Partners cuts target price to $5 from $6.5
* J&J JNJ.N : Credit Suisse initiates coverage with neutral rating; target price $170
* Kelly Services Inc KELYA.O : Barrington Research cuts target price to $24 from $25
* Leap Therapeutics Inc LPTX.O : Baird cuts target price to $4 from $5
* Lucid Diagnostics Inc LUCD.O : BTIG cuts target price to $3.5 from $5
* Macy's Inc M.N : Credit Suisse raises target price to $19 from $17
* Macy's Inc M.N : Jefferies raises target price to $25 from $23
* Macy's Inc M.N : JP Morgan raises target price to $29 from $28
* Merck & Co Inc MRK.N : Credit Suisse initiates coverage with outperform rating
* Merck & Co Inc MRK.N : Credit Suisse initiates coverage with target price $120
* Midwest Holding Inc MDWT.O : Piper Sandler raises target price to $16 from $15
* MorphoSys AG MOR.O : JP Morgan cuts target price to $5 from $8.3
* Natures Sunshine Products Inc NATR.O : D.A. Davidson cuts target price to $15 from $18
* Oncocyte Corp OCX.O : Piper Sandler cuts to neutral from overweight
* Oncocyte Corp OCX.O : Piper Sandler cuts target price to $0.5 from $1
* Onewater Marine Inc ONEW.O : D.A. Davidson cuts target price to $33 from $35
* Pacific Biosciences of California Inc PACB.O : JP Morgan raises target to $13 from $10
* Palo Alto Networks Inc PANW.O : Credit Suisse cuts target price to $225 from $228.33
* Pfizer Inc PFE.N : Credit Suisse initiates coverage with outperform rating
* Pfizer Inc PFE.N : Credit Suisse initiates coverage with target price $55
* Qualigen Therapeutics Inc QLGN.O : Alliance Global Partners cuts target to $4 from
$6.5
* Ross Stores Inc ROST.O : Credit Suisse raises target price to $123 from $99
* Ross Stores Inc ROST.O : Jefferies raises target price to $105 from $85
* Schlumberger NV SLB.N : Jefferies raises target price to $64 from $59
* Scholar Rock Holding Corp SRRK.O : JP Morgan cuts target price to $20 from $38
* Vroom Inc VRM.O : JP Morgan raises to neutral from underweight
* Williams-Sonoma Inc WSM.N : RBC cuts target price to $151 from $192
* Woodward Inc WWD.O : Wells Fargo raises target price to $106 from $100
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Destination XL
See all newsDestination XL Q1 sales fall 2.1%, net loss widens
Brief: Destination Xl Group Provides Update On Pending Merger With Fullbeauty Brands
Brief: Destination XL Q1 EPS USD -0.11
Destination XL Group Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Destination Xl Group Recommends DXL Shareholders Reject Zodiac Partners II’S Tender Offer And Not Tender Their Shares